FDA Drug Application (078712) for CIPROFLOXACIN EXTENDED RELEASE by SANDOZ

Back to FDA Applications sponsored by SANDOZ

Application Number078712
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage212.6MG;EQ 287.5MG BASE
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCIPROFLOXACIN EXTENDED RELEASE
Active IngredientCIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE



Back to FDA Applications sponsored by SANDOZ

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.